Acute Kidney Injury Genomics and Biomarkers in TAVR Study


Phase N/A Results N/A

Summary of Purpose

In the last decade, transcatheter aortic valve replacement (TAVR) has become an increasingly utilized alternative procedure for replacing a stenotic aortic valve. This study collects clinical information, DNA, blood and urine samples (throughout procedural hospitalization) in order to investigate the incidence of acute kidney injury (AKI) in patients undergoing TAVR and to identify key clinical and procedural...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 June 2017.

25 Oct 2016 19 Feb 2016 1 Mar 2031 1 Mar 2031 1 Jun 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample